DcR2 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemDcR2 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-35185
Gene Nametumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
Quantity10 µM
Specieshuman
NCBI Full Gene NameTNF receptor superfamily member 10d
NCBI Gene AliasesCD264, DCR2, TRAIL-R4, TRAILR4, TRUNDD
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Ischemic Preconditioning Upregulates Decoy Receptors to Protect SH-SY5Y Cells from OGD Induced Cellular Damage by Inhibiting TRAIL Pathway and Agitating PI3K/Akt PathwayMolecular neurobiologySeptember 1, 2020Jin W, Xu W, Zhang X, Ren CC.

(2) DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cellsCancer gene therapyDecember 1, 2007Sanlioglu AD, Karacay B, Koksal IT, Griffith TS, Sanlioglu S.so only damaged cells uptake the dye and stain positive. TRAIL-R4 gene silencing using siRNA DcR2 siRNA (sc-35185), siRNA transfection medium (sc-36868) and siRNA transfection reagent (sc-29528) were used with DU145

(3) Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritisRheumatology (Oxford, England)May 1, 2007Terzioglu E, Bisgin A, Sanlioglu AD, Ulker M, Yazisiz V, Tuzuner S, Sanlioglu S.

(4) Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related apoptosis-inducing ligand resistance in lung cancer cellsHuman gene therapyJanuary 1, 2007Aydin C, Sanlioglu AD, Karacay B, Ozbilim G, Dertsiz L, Ozbudak O, Akdis CA, Sanlioglu S.

(5) Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cellsBMC cancerMay 25, 2005Sanlioglu AD, Dirice E, Aydin C, Erin N, Koksoy S, Sanlioglu S.within the last couple of years in research. DcR2 siRNA experiments were performed using DcR2 siRNA (sc-35185), siRNA transfection medium (sc-36868) and siRNA transfection reagent (sc-29528) in MCF7 breast cancer

Be the First to Write a Review!

DcR2 siRNA (h)

DcR2 siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (5)

Reviews

DcR2 siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map